Table 1.
Effect | Substance | Species | Tissue or Cell Type | Type of Study | Analysis of Calcification or Calcification-Associated Process * by |
Reference | Plasma Level in CKD | Classified as Uremic Toxin ** | |
---|---|---|---|---|---|---|---|---|---|
In Vitro | Animal | ||||||||
INHIBITION | Asymmetric dimethylarginine (ADMA) | Human | VSMC | V $ | Alizarin red staining | Schepers [29] | ↑ [§] | V | |
Symmetric dimethylarginine (SDMA) | Human | VSMC | V $ | Alizarin red staining | Schepers [29] | ↑ [§] | V | ||
Guanidinosuccinic acid (GSA) | Human | VSMC | V $ | Alizarin red staining | Schepers [29] | ↑ [§] | V | ||
INDUCTION | Phosphate (P) | Human | VSMC | V | Calcium content Alizarin red staining |
Bouabdallah [30] | ↑ [31] | ||
Human | VSMC | V | Alizarin red staining Upregulation of MSX2, SOX9 and OPN Increased apoptosis |
Cazana-Perez [32] | |||||
Human | VSMC | V | Calcium content Upregulation of CBFA1/RUNX2 and BMP2 |
Guerrero [33] | |||||
Human | VSMC | V | Alizarin red staining | Schepers [29] | |||||
Human | VSMC | V $ | High binding affinity of calcium to ECM | Shigematsu [34] 1 | |||||
Rat | VSMC | V | Von Kossa staining | Shibata [35] | |||||
Rat | Aorta | V | Calcium content | Guerrero [33] | |||||
Mouse | Aorta | V 2 | Von Kossa staining | Belmokhtar [36] | |||||
Mouse | VSMC | V | Alizarin red staining Increased ROS generation Upregulation of PIT-1, BMP2 and CBFA1/RUNX2 |
Belmokhtar [36] | |||||
Mouse | VSMC | V | Upregulation of BMP2 and OPN | Sage [37] 1 | |||||
Rat | Aorta | V 3 | Von Kossa staining | Shibata [35] | |||||
Calcium | Rat | Aorta | V | Calcium content | Azpiazu [38] 1 | ↑ [39] | |||
Human | VSMC | V | Calcium content | Yang [40] 1 | |||||
Cytidine | Human | MSC | V $ | ALP activity Calcium content |
Hegner [41] | ↑ [§] | V | ||
Urea | Human | MSC | V $ | ALP activity Calcium content |
Hegner [41] | ↑ [§] | V | ||
Threitol | Human | MSC | V $ | ALP activity Calcium content |
Hegner [41] | ↑ [§] | V | ||
NO EFFECT | Guanidino compounds: | Human | VSMC | V | Alizarin red staining | Schepers [29] | |||
ADMA | ↑ [§] | V | |||||||
SDMA | ↑ [§] | V | |||||||
GSA | ↑ [§] | V | |||||||
Creatine | ↑ [§] | V | |||||||
Creatinine | ↑ [§] | V | |||||||
Guanidine | ↑ [§] | V | |||||||
Guanidino acetic acid | ↑ [§] | V | |||||||
Guanidino butyric acid | ↑ [§] | V | |||||||
Guanidino propionic acid | ↑ [§] | V | |||||||
Methylguanidine | ↑ [§] | V |
ALP—alkaline phosphatase; BMP2—bone morphogenetic protein 2; CBFA1/RUNX2—core-binding factor subunit alpha-1/runt-related transcription factor 2; CT—computed tomography; ECM—extracellular matrix; MSC–mesenchymal stromal cells (as progenitors of VSMC); MSX2—msh homeobox 2; OPN—osteopontin; PIT-1—sodium Pi co-transporter-1; ROS—reactive oxygen species; SOX9—SRY-box transcription factor 9; VSMC—vascular smooth muscle cells. * Readouts of calcification-associated processes, such as cell signaling and gene/protein expression, are shown in italic. [§] As described in comprehensive uremic toxins reviews [19,20]. ** As described in comprehensive uremic toxins reviews [19,20,21]. $ In pro-calcifying medium. 1 Literature added manually after checking reference lists of included studies or recent reviews. 2 In vivo mouse model: 5/6 nephrectomy in Apoe−/−mice on a high- phosphorus diet vs. 5/6 nephrectomy in Apoe-/- mice on a control diet for twelve weeks. 3 In vivo rat model: 5/6 nephrectomy in rats on a high- phosphorus and low-calcium diet vs. 5/6 nephrectomy in rats on a control diet for eight weeks; ↑ indicates increased plasma levels in CKD patients.